The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 23, 2017
Filed:
Mar. 15, 2013
Applicant:
New York University, New York, NY (US);
Inventors:
Victor J. Torres, New York, NY (US);
Ashley L. Dumont, New York, NY (US);
Assignee:
New York University, New York, NY (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 14/31 (2006.01); C07K 14/435 (2006.01); C07K 14/705 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2845 (2013.01); A61K 38/1741 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 14/31 (2013.01); C07K 14/4354 (2013.01); C07K 14/473 (2013.01); C07K 14/70553 (2013.01); G01N 33/56938 (2013.01); A61K 2039/505 (2013.01); C07K 2317/76 (2013.01); C07K 2319/21 (2013.01);
Abstract
The present invention relates to methods of treating and preventinginfection and/or a condition resulting from ainfection a subject that involves administering a CD11b inhibitor. The present invention further relates to a non-human transgenic animal expressing human CD11b and its use in methods of identifying novel therapeutics for the treatment and prevention ofinfection and/or a condition resulting from ainfection.